Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the marketCNBC • 01/08/25
The Magnificent 7 Blue-Chip Dividend Stocks to Buy in 2025 and Hold Forever24/7 Wall Street • 01/06/25
Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for InvestorsZacks Investment Research • 01/04/25
Bristol Myers Squibb to Present at J.P. Morgan's 43rd Annual Healthcare ConferenceBusiness Wire • 01/03/25
Bristol-Myers Squibb Stock: Clearly Undervalued, Excellent 2H24 Culminates In Opdivo 'Subcu' ApprovalSeeking Alpha • 12/30/24
U.S. Food and Drug Administration Approves Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) Injection, for Subcutaneous Use in Most Previously Approved Adult, Solid Tumor Opdivo® (nivolumab) Indications1,2Business Wire • 12/27/24
BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal CancerZacks Investment Research • 12/24/24
Bristol Myers Squibb Announces Positive Topline Results from Two Pivotal Phase 3 Trials Evaluating Sotyktu (deucravacitinib) in Adults with Psoriatic ArthritisBusiness Wire • 12/23/24
Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal CancerBusiness Wire • 12/23/24
Bristol-Myers Squibb: Rich Dividends & Double-Digits Upside Potential - Bright 2026 ProspectsSeeking Alpha • 12/20/24
3 High-Yielding Dividend Stocks That Retirees Can Rely On for Recurring IncomeThe Motley Fool • 12/19/24
Imbed Biosciences Appoints Bristol Myers Squibb Veteran Terry Bromley as Chief Executive OfficerBusiness Wire • 12/19/24
Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025Business Wire • 12/19/24
These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?The Motley Fool • 12/19/24
BioArctic announces global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody programPRNewsWire • 12/19/24
Fangzhou Inc. and Bristol Myers Squibb China Join Forces on a Strategic Alliance to Advance Internet HealthcarePRNewsWire • 12/19/24